Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Patricia Buehler, MD, MPH

Advertisement

Articles by Patricia Buehler, MD, MPH

Patricia Buehler, MD, MPH, at ASCRS 2025

ASCRS 2025: A noninvasive approach to blepharoplasty reduces recovery time, bruising

ByPatricia Buehler, MD, MPH,Emily Kaiser Maharjan, Assistant Managing Editor,Hattie Hayes,Sheryl Stevenson, Eye Care Group Editorial Director
May 1st 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Optometry Times - Clinical News & Expert Optometrist Insights

    1

    FDA approves Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for presbyopia

    2

    MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension

    3

    Study finds artificial tear viscosity and shear-thinning behavior vary by formulation

    4

    FDA clears Novaliq’s Investigational New Drug application for NOV05

    5

    FDA approves NDA labeling supplement allowing re-administration of iDose TR

    • Advertise
    • About Us
    • Editorial
    • Contact Us
    • Job Board
    • Terms & Conditions
    • Privacy
    • Do not sell my Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    • Ophthalmology Times
    • Modern Retina
    • Optometry Times
    • Ophthalmology Times Europe
    Collaborative Care Symposium
    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us